High efficacy reported for Sputnik V COVID-19 vaccine

COVID-19 vaccine developed with new platform proves effective in mice
4 February 2021
Researchers find a more accurate method to gauge prenatal alcohol use
4 February 2021

High efficacy reported for Sputnik V COVID-19 vaccine

(HealthDay)—A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), has 91.6 percent efficacy against COVID-19, according to a study published online Feb. 2 in The Lancet.

Comments are closed.